login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CYCLO THERAPEUTICS INC (CYTH) Stock News
USA
- NASDAQ:CYTH -
US23254X2018
-
Common Stock
0.7206
USD
+0.01 (+1.39%)
Last: 3/25/2025, 8:00:01 PM
0.7199
USD
0 (-0.1%)
After Hours:
3/25/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CYTH Latest News, Press Relases and Analysis
All
Press Releases
7 months ago - By: Rafael Holdings, Inc.
- Mentions:
RFL
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
7 months ago - By: Benzinga
- Mentions:
PTN
CAPS
BSGM
POAI
...
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
7 months ago - By: Benzinga
- Mentions:
IBO
INTS
EYEN
PSTV
...
12 Health Care Stocks Moving In Thursday's After-Market Session
7 months ago - By: Rafael Holdings, Inc.
- Mentions:
RFL
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results
8 months ago - By: Kahn Swick & Foti, LLC
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH
8 months ago - By: Cyclo Therapeutics, Inc.
Cyclo Therapeutics Presents Positive Preliminary Data from Ongoing Phase 3 TransportNPC™ Open-Label Sub-Study in Patients (< 3 Years Old)
9 months ago - By: Cyclo Therapeutics, Inc.
Cyclo Therapeutics to Present at the 21st Annual WORLDSymposium™ 2025
10 months ago - By: Halper Sadeh LLP
- Mentions:
SKGR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LTRPA, LTRPB, CYTH, SKGR on Behalf of Shareholders
10 months ago - By: Halper Sadeh LLC
- Mentions:
USAP
FLIC
ARCH
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, FLIC, ARCH, CYTH on Behalf of Shareholders
10 months ago - By: Halper Sadeh LLC
- Mentions:
ZUO
ARCH
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, ARCH, CYTH on Behalf of Shareholders
10 months ago - By: Rafael Holdings, Inc.
- Mentions:
RFL
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results
10 months ago - By: Halper Sadeh LLC
- Mentions:
ENLC
ALVR
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENLC, ALVR, CYTH on Behalf of Shareholders
10 months ago - By: Halper Sadeh LLC
- Mentions:
USAP
ARCH
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, CYTH, ARCH on Behalf of Shareholders
a year ago - By: Cyclo Therapeutics, Inc.
Cyclo Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
a year ago - By: Rafael Holdings, Inc.
- Mentions:
RFL
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
a year ago - By: Pacira BioSciences
- Mentions:
PCRX
Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer
a year ago - By: Brodsky & Smith LLC
- Mentions:
CFB
BUSE
ARCH
CEIX
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (Nasdaq - CFB), Arch Resources, Inc. (NYSE - ARCH), Cyclo Therapeutics, Inc. (Nasdaq - CYTH), Vector Group Ltd. (NYSE - VGR)
a year ago - By: Cyclo Therapeutics
Cyclo Therapeutics Presents Encouraging Preliminary Safety Data from Ongoing Pivotal Phase 3 Study and Substudy for the Treatment of Niemann-Pick Disease Type C1 (NPC1)
a year ago - By: Halper Sadeh LLC
- Mentions:
VGR
ARCH
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, ARCH, CYTH on Behalf of Shareholders
a year ago - By: Brodsky & Smith LLC
- Mentions:
CFB
ARCH
VGR
BUSE
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CrossFirst Bankshares, Inc. (Nasdaq - CFB), Arch Resources, Inc. (NYSE - ARCH), Cyclo Therapeutics, Inc. (Nasdaq - CYTH), Vector Group Ltd. (NYSE - VGR)
a year ago - By: Kahn Swick & Foti, LLC
CYCLO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cyclo Therapeutics, Inc. - CYTH
a year ago - By: Halper Sadeh LLC
- Mentions:
VGR
SDIG
ARCH
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VGR, SDIG, ARCH, CYTH on Behalf of Shareholders
a year ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Cyclo Therapeutics, Inc. has obtained a Fair Price for its Public Shareholders
Please enable JavaScript to continue using this application.